The present invention concerns methods of administering a therapeutically effective dose of a sorbent for an inflammatory mediator to a patient where the inflammatory mediator is one or more of enzymes, cytokines, prostaglandins, eicosanoids, leukotrienes, kinins, complement, coagulation factors, endotoxins, enterotoxins, lipopolysaccharide, cell fragments, bile salts, fatty acids, phospholipids, interferon and immunomodulatory antibodies, biologics or drugs.

An object of the present invention is to provide a silica powder having enhanced handleability and quantitative feeding performance, a purification kit for a biomaterial, wherein a plurality of individual compartments of a container are filled with the accurately and quantitatively determined silica powder, and a production method for the kit, and the like. The silica powder for quantitative feeding is a silica powder, wherein 99 mass % or more of particles pass through when the silica powder is sieved through a sieve with a nominal mesh opening of 250 m in accordance with JIS standard sieve list (JIS Z8801-1982) for 1 minute, and a mass change on a sieve with a nominal mesh opening of 106 m is 1 mass % or less, when the silica powder is sieved through the sieve for 1 minute.

This disclosure describes a composite filter aid containing a structured composite material formed by agglomerating an mineral with a protein-adsorbing binder, in which structured composite material includes a particle of the protein-adsorbing binder bonded to a plurality of particles of the mineral, and a permeability of the structured composite material is greater than permeabilities of both of the mineral and the protein-adsorbing binder. Also disclosed herein are processes for making composite filter aids and filtering methods using the composite filter aids.

Disclosed are sol gel derived materials obtained from at least one first precursor and at least one second precursor, as well as sol gel derived compositions containing a plurality of alkylsiloxy substituents obtained from such sol-gel derived materials.

In one aspect, the present invention provides a chromatographic stationary phase material for various different modes of chromatography represented by Formula 1: [X](W).sub.a(Q).sub.b(T).sub.c (Formula 1). X can be a high purity chromatographic core composition having a surface comprising a silica core material, metal oxide core material, an inorganic-organic hybrid material or a group of block copolymers thereof. W can be absent and/or can include hydrogen and/or can include a hydroxyl on the surface of X. Q can be a functional group that minimizes retention variation over time (drift) under chromatographic conditions utilizing low water concentrations. T can include one or more hydrophilic, polar, ionizable, and/or charged functional groups that chromatographically interact with the analyte. Additionally, b and c can be positive numbers, with the ratio 0.05?(b/c)?100, and a?0.

The present invention provides an acidic gas adsorbent having improved heat resistance. The acidic gas adsorbent of the present invention includes a porous body, and an amine compound being a solid and being supported on surfaces of pores of the porous body. The acidic gas adsorbent includes, for example, a cover layer covering the surfaces of the pores of the porous body, and the cover layer includes the amine compound. As an example, when each pore of the porous body is assumed to have a spherical shape, the cover layer has a thickness of 5.0 nm or less, the thickness being calculated from the average pore diameter of the porous body, the pore volume of the porous body, and the pore volume of the acidic gas adsorbent.

Siloxane compounds are removed from the atmospheres by silica supporting an organic sulfonic acid compound. The silica with the organic sulfonic acid compound has a specific surface area down to 500 m.sup.2/g and up to 750 m.sup.2/g and a pore volume down to 0.8 m.sup.3/g and up to 1.2 m.sup.3/g, both measured by nitrogen gas adsorption method and has a pore diameter down to 4 nm and up to 8 nm, at the peak of differential pore volume measured by nitrogen gas adsorption method. The durability of gas sensing element against siloxanes is improved.

The present invention relates to a water-stable Titanium-based metal-organic framework (MOF) material having a high degree of condensation, i.e. an oxo to Ti ratio (or oxo to metal ratio, in the case of doped Ti-based MOFs) >1.0; a process of preparing same and uses thereof, particularly for heterogeneously catalyzed chemical reactions, for gas storage/separation/purification, for information storage, laser printing or as an oxygen indicator, or as proton conductive material (fuel cells), optoelectronic material (photovoltaic cells including Grtzel cells), as a matrix for encapsulating active principles (medicaments, cosmetics), or else as sensing material.

The present disclosure pertains to methods of capturing CO.sub.2 from an environment at pressures above 1 bar by associating the environment with a porous material that has a surface area of at least 2,800 m.sup.2/g, and a total pore volume of at least 1.35 cm.sup.3/g, where a majority of pores of the porous material have diameters of less than 2 nm. The present disclosure also pertains to methods for the separation of CO.sub.2 from natural gas in an environment at partial pressures of either component above 1 bar by associating the environment with a porous material that has a surface area of at least 2,200 m.sup.2/g, and a total pore volume of at least 1.00 cm.sup.3/g, where a majority of pores of the porous material have diameters of greater than 1 nm and less than 2 nm.

A filter apparatus for removing small molecule chemotherapy agents from blood is provided. The filter apparatus comprises a housing with an extraction media comprised of polymer coated carbon cores. Also provided are methods of treating a subject with cancer of an organ or region comprising administering a chemotherapeutic agent to the organ or region, collecting blood laded with chemotherapeutic agent from the isolated organ, filtering the blood laden with chemotherapeutic agent to reduce the chemotherapeutic agent in the blood and returning the blood to the subject.